Loading...

National Institute of Mental Health Data Archive (NDA) Sign In
National Institute of Mental Health Data Archive (NDA) Sign In
NDA

Success! An email is on its way!

Please check your email to complete the linking process. The link you receive is only valid for 30 minutes.

Check your spam or junk folder if you do not receive the email in the next few minutes.

Warning Notice This is a U.S. Government computer system, which may be accessed and used only for authorized Government business by authorized personnel. Unauthorized access or use of this computer system may subject violators to criminal, civil, and/or administrative action. All information on this computer system may be intercepted, recorded, read, copied, and disclosed by and to authorized personnel for official purposes, including criminal investigations. Such information includes sensitive data encrypted to comply with confidentiality and privacy requirements. Access or use of this computer system by any person, whether authorized or unauthorized, constitutes consent to these terms. There is no right of privacy in this system.
Create or Link an Existing NDA Account
NIMH Data Archive (NDA) Sign In or Create An Account
Update Password

You have logged in with a temporary password. Please update your password. Passwords must contain 8 or more characters and must contain at least 3 of the following types of characters:

  • Uppercase
  • Lowercase
  • Numbers
  • Special Characters limited to: %,_,!,@,#,$,-,%,&,+,=,),(,*,^,:,;

Subscribe to our mailing list

Mailing List(s)
Email Format

You are now leaving the NIMH Data Archive (NDA) web site to go to:

Click on the address above if the page does not change within 10 seconds.

Disclaimer

NDA is not responsible for the content of this external site and does not monitor other web sites for accuracy.

Accept Terms
Data Access Terms - Decline Terms

Are you sure you want to cancel? This will decline terms and you will not be authorized for access.

1 Numbers reported are subjects by age
New Trial
New Project

Format should be in the following format: Activity Code, Institute Abbreviation, and Serial Number. Grant Type, Support Year, and Suffix should be excluded. For example, grant 1R01MH123456-01A1 should be entered R01MH123456

Please select an experiment type below

Collection - Use Existing Experiment
To associate an experiment to the current collection, just select an axperiment from the table below then click the associate experiment button to persist your changes (saving the collection is not required). Note that once an experiment has been associated to two or more collections, the experiment will not longer be editable.

The table search feature is case insensitive and targets the experiment id, experiment name and experiment type columns. The experiment id is searched only when the search term entered is a number, and filtered using a startsWith comparison. When the search term is not numeric the experiment name is used to filter the results.
SelectExperiment IdExperiment NameExperiment Type
Created On
24HI-NGS_R1Omics02/16/2011
475MB1-10 (CHOP)Omics06/07/2016
490Illumina Infinium PsychArray BeadChip AssayOmics07/07/2016
501PharmacoBOLD Resting StatefMRI07/27/2016
506PVPREFOmics08/05/2016
509ABC-CT Resting v2EEG08/18/2016
13Comparison of FI expression in Autistic and Neurotypical Homo SapiensOmics12/28/2010
18AGRE/Broad Affymetrix 5.0 Genotype ExperimentOmics01/06/2011
22Stitching PCR SequencingOmics02/14/2011
26ASD_MethylationOmics03/01/2011
29Microarray family 03 (father, mother, sibling)Omics03/24/2011
37Standard paired-end sequencing of BCRsOmics04/19/2011
38Illumina Mate-Pair BCR sequencingOmics04/19/2011
39Custom Jumping LibrariesOmics04/19/2011
40Custom CapBPOmics04/19/2011
41ImmunofluorescenceOmics05/11/2011
43Autism brain sample genotyping, IlluminaOmics05/16/2011
47ARRA Autism Sequencing Collaboration at Baylor. SOLiD 4 SystemOmics08/01/2011
53AGRE Omni1-quadOmics10/11/2011
59AGP genotypingOmics04/03/2012
60Ultradeep 454 sequencing of synaptic genes from postmortem cerebella of individuals with ASD and neurotypical controlsOmics06/23/2012
63Microemulsion PCR and Targeted Resequencing for Variant Detection in ASDOmics07/20/2012
76Whole Genome Sequencing in Autism FamiliesOmics01/03/2013
519RestingfMRI11/08/2016
90Genotyped IAN SamplesOmics07/09/2013
91NJLAGS Axiom Genotyping ArrayOmics07/16/2013
93AGP genotyping (CNV)Omics09/06/2013
106Longitudinal Sleep Study. H20 200. Channel set 2EEG11/07/2013
107Longitudinal Sleep Study. H20 200. Channel set 3EEG11/07/2013
108Longitudinal Sleep Study. AURA 200EEG11/07/2013
105Longitudinal Sleep Study. H20 200. Channel set 1EEG11/07/2013
109Longitudinal Sleep Study. AURA 400EEG11/07/2013
116Gene Expression Analysis WG-6Omics01/07/2014
131Jeste Lab UCLA ACEii: Charlie Brown and Sesame Street - Project 1Eye Tracking02/27/2014
132Jeste Lab UCLA ACEii: Animacy - Project 1Eye Tracking02/27/2014
133Jeste Lab UCLA ACEii: Mom Stranger - Project 2Eye Tracking02/27/2014
134Jeste Lab UCLA ACEii: Face Emotion - Project 3Eye Tracking02/27/2014
145AGRE/FMR1_Illumina.JHUOmics04/14/2014
146AGRE/MECP2_Sanger.JHUOmics04/14/2014
147AGRE/MECP2_Junior.JHUOmics04/14/2014
151Candidate Gene Identification in familial AutismOmics06/09/2014
152NJLAGS Whole Genome SequencingOmics07/01/2014
154Math Autism Study - Vinod MenonfMRI07/15/2014
155RestingfMRI07/25/2014
156SpeechfMRI07/25/2014
159EmotionfMRI07/25/2014
160syllable contrastEEG07/29/2014
167School-age naturalistic stimuliEye Tracking09/19/2014
44AGRE/Broad Affymetrix 5.0 Genotype ExperimentOmics06/27/2011
45Exome Sequencing of 20 Sporadic Cases of Autism Spectrum DisorderOmics07/15/2011
Collection - Add Experiment
Add Supporting Documentation
Select File

To add an existing Data Structure, enter its title in the search bar. If you need to request changes, select the indicator "No, it requires changes to meet research needs" after selecting the Structure, and upload the file with the request changes specific to the selected Data Structure. Your file should follow the Request Changes Procedure. If the Data Structure does not exist, select "Request New Data Structure" and upload the appropriate zip file.

Request Submission Exemption
Characters Remaining:
Not Eligible

The Data Expected list for this Collection shows some raw data as missing. Contact the NDA Help Desk with any questions.

Please confirm that you will not be enrolling any more subjects and that all raw data has been collected and submitted.

Collection Updated

Your Collection is now in Data Analysis phase and exempt from biannual submissions. Analyzed data is still expected prior to publication or no later than the project end date.

[CMS] Attention
[CMS] Please confirm that you will not be enrolling any more subjects and that all raw data has been collected and submitted.
[CMS] Error

[CMS]

Unable to change collection phase where targeted enrollment is less than 90%

Delete Submission Exemption
Are you sure you want to delete this submission exemption?
You have requested to move the sharing dates for the following assessments:
Data Expected Item Original Sharing Date New Sharing Date

Please provide a reason for this change, which will be sent to the Program Officers listed within this collection:

Explanation must be between 20 and 200 characters in length.

Please press Save or Cancel
Add New Email Address - Dialog
New Email Address
Collection Summary Collection Charts
Collection Title Collection Investigators Collection Description
DCTRS Cognitive Enhancement Therapy for Early-Course Schizophrenia: Effects of a Two-Year Randomized Controlled Trial
Matcheri S. Keshavan 
The early application of cognitive rehabilitation may afford long-term functional benefits to patients with schizophrenia. This study examined the two-year effects of an integrated neurocognitive and social-cognitive rehabilitation program, cognitive enhancement therapy (CET), on cognitive and functional outcomes in early course schizophrenia.
NIMH Data Archive
05/20/2014
Funding Completed
Close Out
No
$5,716,691.00
58
Loading Chart...
NIH - Extramural None

Keshavan nimh_essence_datarelease variable names.txt Software Data dictionary Qualified Researchers


R01MH060902-01 Rehabilitation, Brain Function and Early Schizophrenia 08/15/2001 07/31/2007 186 69 UNIVERSITY OF PITTSBURGH AT PITTSBURGH $2,662,308.00
R01MH092440-01 Brain Imaging, Cognitive Enhancement and Early Schizophrenia 06/01/2012 03/31/2018 0 108 BETH ISRAEL DEACONESS MEDICAL CENTER $3,054,383.00

This study will determine the effectiveness of cognitive enhancement therapy (CET) in treating cognitive abnormalities in people experiencing the early stages of schizophrenia. Completed NCT00167362 R01MH060902 Matcheri S Keshavan, MD August 2001 December 2016
helpcenter.collection.general-tab

NDA Help Center

Collection - General Tab

Fields available for edit on the top portion of the page include:

  • Collection Title
  • Investigators
  • Collection Description
  • Collection Phase
  • Funding Source
  • Clinical Trials

Collection Phase: The current status of a research project submitting data to an NDA Collection, based on the timing of the award and/or the data that have been submitted.

  • Pre-Enrollment: The default entry made when the NDA Collection is created.
  • Enrolling: Data have been submitted to the NDA Collection or the NDA Data Expected initial submission date has been reached for at least one data structure category in the NDA Collection.
  • Data Analysis: Subject level data collection for the research project is completed and has been submitted to the NDA Collection. The NDA Collection owner or the NDA Help Desk may set this phase when they’ve confirmed data submission is complete and submitted subject counts match at least 90% of the target enrollment numbers in the NDA Data Expected. Data submission reminders will be turned off for the NDA Collection.
  • Funding Completed: The NIH grant award (or awards) associated with the NDA Collection has reached its end date. NDA Collections in Funding Completed phase are assigned a subphase to indicate the status of data submission.
    • The Data Expected Subphase indicates that NDA expects more data will be submitted
    • The Closeout Subphase indicates the data submission is complete.
    • The Sharing Not Met Subphase indicates that data submission was not completed as expected.

Blinded Clinical Trial Status:

  • This status is set by a Collection Owner and indicates the research project is a double blinded clinical trial. When selected, the public view of Data Expected will show the Data Expected items and the Submission Dates, but the targeted enrollment and subjects submitted counts will not be displayed.
  • Targeted enrollment and subjects submitted counts are visible only to NDA Administrators and to the NDA Collection or as the NDA Collection Owner.
  • When an NDA Collection that is flagged Blinded Clinical Trial reaches the maximum data sharing date for that Data Repository (see https://nda.nih.gov/nda/sharing-regimen.html), the embargo on Data Expected information is released.

Funding Source

The organization(s) responsible for providing the funding is listed here.

Supporting Documentation

Users with Submission privileges, as well as Collection Owners, Program Officers, and those with Administrator privileges, may upload and attach supporting documentation. By default, supporting documentation is shared to the general public, however, the option is also available to limit this information to qualified researchers only.

Grant Information

Identifiable details are displayed about the Project of which the Collection was derived from. You may click in the Project Number to view a full report of the Project captured by the NIH.

Clinical Trials

Any data that is collected to support or further the research of clinical studies will be available here. Collection Owners and those with Administrator privileges may add new clinical trials.

Frequently Asked Questions

  • How does the NIMH Data Archive (NDA) determine which Permission Group data are submitted into?
    During Collection creation, NDA staff determine the appropriate Permission Group based on the type of data to be submitted, the type of access that will be available to data access users, and the information provided by the Program Officer during grant award.
  • How do I know when a NDA Collection has been created?
    When a Collection is created by NDA staff, an email notification will automatically be sent to the PI(s) of the grant(s) associated with the Collection to notify them.
  • Is a single grant number ever associated with more than one Collection?
    The NDA system does not allow for a single grant to be associated with more than one Collection; therefore, a single grant will not be listed in the Grant Information section of a Collection for more than one Collection.
  • Why is there sometimes more than one grant included in a Collection?
    In general, each Collection is associated with only one grant; however, multiple grants may be associated if the grant has multiple competing segments for the same grant number or if multiple different grants are all working on the same project and it makes sense to hold the data in one Collection (e.g., Cooperative Agreements).

Glossary

  • Administrator Privilege
    A privilege provided to a user associated with an NDA Collection or NDA Study whereby that user can perform a full range of actions including providing privileges to other users.
  • Collection Owner
    Generally, the Collection Owner is the contact PI listed on a grant. Only one NDA user is listed as the Collection owner. Most automated emails are primarily sent to the Collection Owner.
  • Collection Phase
    The Collection Phase provides information on data submission as opposed to grant/project completion so while the Collection phase and grant/project phase may be closely related they are often different. Collection users with Administrative Privileges are encouraged to edit the Collection Phase. The Program Officer as listed in eRA (for NIH funded grants) may also edit this field. Changes must be saved by clicking the Save button at the bottom of the page. This field is sortable alphabetically in ascending or descending order. Collection Phase options include:
    • Pre-Enrollment: A grant/project has started, but has not yet enrolled subjects.
    • Enrolling: A grant/project has begun enrolling subjects. Data submission is likely ongoing at this point.
    • Data Analysis: A grant/project has completed enrolling subjects and has completed all data submissions.
    • Funding Completed: A grant/project has reached the project end date.
  • Collection Title
    An editable field with the title of the Collection, which is often the title of the grant associated with the Collection.
  • Grant
    Provides the grant number(s) for the grant(s) associated with the Collection. The field is a hyperlink so clicking on the Grant number will direct the user to the grant information in the NIH Research Portfolio Online Reporting Tools (RePORT) page.
  • Supporting Documentation
    Various documents and materials to enable efficient use of the data by investigators unfamiliar with the project and may include the research protocol, questionnaires, and study manuals.
  • NIH Research Initiative
    NDA Collections may be organized by scientific similarity into NIH Research Initiatives, to facilitate query tool user experience. NIH Research Initiatives map to one or multiple Funding Opportunity Announcements.
  • Permission Group
    Access to shared record-level data in NDA is provisioned at the level of a Permission Group. NDA Permission Groups consist of one or multiple NDA Collections that contain data with the same subject consents.
  • Planned Enrollment
    Number of human subject participants to be enrolled in an NIH-funded clinical research study. The data is provided in competing applications and annual progress reports.
  • Actual Enrollment
    Number of human subjects enrolled in an NIH-funded clinical research study. The data is provided in annual progress reports.
  • NDA Collection
    A virtual container and organization structure for data and associated documentation from one grant or one large project/consortium. It contains tools for tracking data submission and allows investigators to define a wide array of other elements that provide context for the data, including all general information regarding the data and source project, experimental parameters used to collect any event-based data contained in the Collection, methods, and other supporting documentation. They also allow investigators to link underlying data to an NDA Study, defining populations and subpopulations specific to research aims.
  • Data Use Limitations
    Data Use Limitations (DULs) describe the appropriate secondary use of a dataset and are based on the original informed consent of a research participant. NDA only accepts consent-based data use limitations defined by the NIH Office of Science Policy.
  • Total Subjects Shared
    The total number of unique subjects for whom data have been shared and are available for users with permission to access data.
IDNameCreated DateStatusType
No records found.
helpcenter.collection.experiments-tab

NDA Help Center

Collection - Experiments

The number of Experiments included is displayed in parentheses next to the tab name. You may download all experiments associated with the Collection via the Download button. You may view individual experiments by clicking the Experiment Name and add them to the Filter Cart via the Add to Cart button.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may create or edit an Experiment.

Please note: The creation of an NDA Experiment does not necessarily mean that data collected, according to the defined Experiment, has been submitted or shared.

Frequently Asked Questions

  • Can an Experiment be associated with more than one Collection?

    Yes -see the “Copy” button in the bottom left when viewing an experiment. There are two actions that can be performed via this button:

    1. Copy the experiment with intent for modifications.
    2. Associate the experiment to the collection. No modifications can be made to the experiment.

Glossary

  • Experiment Status
    An Experiment must be Approved before data using the associated Experiment_ID may be uploaded.
  • Experiment ID
    The ID number automatically generated by NDA which must be included in the appropriate file when uploading data to link the Experiment Definition to the subject record.
Clinical Trials: Mixed Assessments Clinical Assessments 58
helpcenter.collection.shared-data-tab

NDA Help Center

Collection - Shared Data

This tab provides a quick overview of the Data Structure title, Data Type, and Number of Subjects that are currently Shared for the Collection. The information presented in this tab is automatically generated by NDA and cannot be edited. If no information is visible on this tab, this would indicate the Collection does not have shared data or the data is private.

The shared data is available to other researchers who have permission to access data in the Collection's designated Permission Group(s). Use the Download button to get all shared data from the Collection to the Filter Cart.

Frequently Asked Questions

  • How will I know if another researcher uses data that I shared through the NIMH Data Archive (NDA)?
    To see what data your project have submitted are being used by a study, simply go the Associated Studies tab of your collection. Alternatively, you may review an NDA Study Attribution Report available on the General tab.
  • Can I get a supplement to share data from a completed research project?
    Often it becomes more difficult to organize and format data electronically after the project has been completed and the information needed to create a GUID may not be available; however, you may still contact a program staff member at the appropriate funding institution for more information.
  • Can I get a supplement to share data from a research project that is still ongoing?
    Unlike completed projects where researchers may not have the information needed to create a GUID and/or where the effort needed to organize and format data becomes prohibitive, ongoing projects have more of an opportunity to overcome these challenges. Please contact a program staff member at the appropriate funding institution for more information.

Glossary

  • Data Structure
    A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure
  • Data Type
    A grouping of data by similar characteristics such as Clinical Assessments, Omics, or Neurosignal data.
  • Shared
    The term 'Shared' generally means available to others; however, there are some slightly different meanings based on what is Shared. A Shared NDA Study is viewable and searchable publicly regardless of the user's role or whether the user has an NDA account. A Shared NDA Study does not necessarily mean that data used in the NDA Study have been shared as this is independently determined. Data are shared according the schedule defined in a Collection's Data Expected Tab and/or in accordance with data sharing expectations in the NDA Data Sharing Terms and Conditions. Additionally, Supporting Documentation uploaded to a Collection may be shared independent of whether data are shared.

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Publications

Publications relevant to NDA data are listed below. Most displayed publications have been associated with the grant within Pubmed. Use the "+ New Publication" button to add new publications. Publications relevant/not relevant to data expected are categorized. Relevant publications are then linked to the underlying data by selecting the Create Study link. Study provides the ability to define cohorts, assign subjects, define outcome measures and lists the study type, data analysis and results. Analyzed data and results are expected in this way.

PubMed IDStudyTitleJournalAuthorsDateStatus
38281419Create StudySymptom contributors to quality of life in schizophrenia: Exploratory factor and network analyses.Schizophrenia researchMurphy, Samuel M; Flores, Ana T; Wojtalik, Jessica A; Keshavan, Matcheri S; Eack, Shaun MFebruary 1, 2024Not Determined
37267670Create StudyPredictors of treatment discontinuation during an 18-month multi-site randomized trial of Cognitive Enhancement Therapy for early course schizophrenia.Psychiatry researchWojtalik, Jessica A; Brown, Wilson J; Mesholam-Gately, Raquelle I; Kotwani, Anju; Keshavan, Matcheri S; Eack, Shaun MAugust 1, 2023Not Determined
35982257Create StudyCognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study.Molecular psychiatrySeitz-Holland, Johanna; Wojcik, Joanne D; Cetin-Karayumak, Suheyla; Lyall, Amanda E; Pasternak, Ofer; Rathi, Yogesh; Vangel, Mark; Pearlson, Godfrey; Tamminga, Carol; Sweeney, John A; Clementz, Brett A; Schretlen, David A; Viher, Petra Verena; Stegmayer, Katharina; Walther, Sebastian; Lee, Jungsun; Crow, Tim; James, Anthony; Voineskos, Aristotle; Buchanan, Robert W; Szeszko, Philip R; Malhotra, Anil K; Kelly, Sinead; Shenton, Martha E; Keshavan, Matcheri S; Mesholam-Gately, Raquelle I; Kubicki, MarekSeptember 1, 2022Not Determined
35636031Create StudyCognitive gains as a mechanism of functional capacity improvement in schizophrenia: Results from a multi-site randomized controlled trial.Journal of psychiatric researchFlores, Ana T; Hogarty, Susan S; Mesholam-Gately, Raquelle I; Barrio, Concepción; Keshavan, Matcheri S; Eack, Shaun MJuly 1, 2022Not Determined
35044886Create StudyPremorbid Sociality Moderates Social Adjustment Change during Cognitive Enhancement Therapy for Adults with Early Schizophrenia.Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53Wojtalik, Jessica A; Flores, Ana T; Keshavan, Matcheri S; Eack, Shaun MJanuary 1, 2022Not Determined
34470506Create StudyConfirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial.Psychiatric services (Washington, D.C.)Wojtalik, Jessica A; Mesholam-Gately, Raquelle I; Hogarty, Susan S; Greenwald, Deborah P; Litschge, Maralee Y; Sandoval, Luis R; Shashidhar, Gautami; Guimond, Synthia; Keshavan, Matcheri S; Eack, Shaun MMay 1, 2022Not Determined
33483689Create StudyElucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia-a multicenter harmonized diffusion tensor imaging study.Molecular psychiatrySeitz-Holland, Johanna; Cetin-Karayumak, Suheyla; Wojcik, Joanne D; Lyall, Amanda; Levitt, James; Shenton, Martha E; Pasternak, Ofer; Westin, Carl-Fredrik; Baxi, Madhura; Kelly, Sinead; Mesholam-Gately, Raquelle; Vangel, Mark; Pearlson, Godfrey; Tamminga, Carol A; Sweeney, John A; Clementz, Brett A; Schretlen, David; Viher, Petra Verena; Stegmayer, Katharina; Walther, Sebastian; Lee, Jungsun; Crow, Tim; James, Anthony; Voineskos, Aristotle; Buchanan, Robert W; Szeszko, Philip R; Malhotra, Anil K; Rathi, Yogesh; Keshavan, Matcheri; Kubicki, MarekSeptember 1, 2021Not Determined
33329111Create StudyCerebellar-Cortical Connectivity Is Linked to Social Cognition Trans-Diagnostically.Frontiers in psychiatryBrady Jr, Roscoe O; Beermann, Adam; Nye, Madelaine; Eack, Shaun M; Mesholam-Gately, Raquelle; Keshavan, Matcheri S; Lewandowski, Kathryn EJanuary 1, 2020Not Determined
33183362Create StudyFunctional connectivity associated with improvement in emotion management after cognitive enhancement therapy in early-course schizophrenia.Psychological medicineGuimond, Synthia; Ling, George; Drodge, Jessica; Matheson, Hannah; Wojtalik, Jessica A; Lopez, Betzamel; Collin, Guusje; Brady, Roscoe; Mesholam-Gately, Raquelle I; Thermenos, Heidi; Eack, Shaun M; Keshavan, Matcheri SSeptember 1, 2022Not Determined
32851404Create StudyInvestigating Sexual Dimorphism of Human White Matter in a Harmonized, Multisite Diffusion Magnetic Resonance Imaging Study.Cerebral cortex (New York, N.Y. : 1991)Seitz, Johanna; Cetin-Karayumak, Suheyla; Lyall, Amanda; Pasternak, Ofer; Baxi, Madhura; Vangel, Mark; Pearlson, Godfrey; Tamminga, Carol; Sweeney, John; Clementz, Brett; Schretlen, David; Viher, Petra Verena; Stegmayer, Katharina; Walther, Sebastian; Lee, Jungsun; Crow, Tim; James, Anthony; Voineskos, Aristotle; Buchanan, Robert W; Szeszko, Philip R; Malhotra, Anil; Keshavan, Matcheri; Koerte, Inga K; Shenton, Martha E; Rathi, Yogesh; Kubicki, MarekJanuary 1, 2021Not Determined
32648915Create StudyIndividual Variation in Functional Brain Network Topography is Linked to Schizophrenia Symptomatology.Schizophrenia bulletinNawaz, Uzma; Lee, Ivy; Beermann, Adam; Eack, Shaun; Keshavan, Matcheri; Brady, RoscoeJanuary 23, 2021Not Determined
31759574Create StudyNeuroimaging in Schizophrenia.Neuroimaging clinics of North AmericaKeshavan, Matcheri S; Collin, Guusje; Guimond, Synthia; Kelly, Sinead; Prasad, Konasale M; Lizano, PauloFebruary 1, 2020Not Determined
31511636Create StudyWhite matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study.Molecular psychiatryCetin-Karayumak, Suheyla; Di Biase, Maria A; Chunga, Natalia; Reid, Benjamin; Somes, Nathaniel; Lyall, Amanda E; Kelly, Sinead; Solgun, Bengisu; Pasternak, Ofer; Vangel, Mark; Pearlson, Godfrey; Tamminga, Carol; Sweeney, John A; Clementz, Brett; Schretlen, David; Viher, Petra Verena; Stegmayer, Katharina; Walther, Sebastian; Lee, Jungsun; Crow, Tim; James, Anthony; Voineskos, Aristotle; Buchanan, Robert W; Szeszko, Philip R; Malhotra, Anil K; Hegde, Rachal; McCarley, Robert; Keshavan, Matcheri; Shenton, Martha; Rathi, Yogesh; Kubicki, MarekDecember 2020Not Determined
31298174Create StudyTransdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum.Psychological medicineKuo, Susan S; Wojtalik, Jessica A; Mesholam-Gately, Raquelle I; Keshavan, Matcheri S; Eack, Shaun MJuly 2020Not Determined
31163301Create StudyEstablishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT).Psychiatry researchKuo, Susan S; Wojtalik, Jessica A; Mesholam-Gately, Raquelle I; Keshavan, Matcheri S; Eack, Shaun MAugust 2019Not Determined
30696271Create StudyCerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia.The American journal of psychiatryBrady RO, Gonsalvez I, Lee I, Öngür D, Seidman LJ, Schmahmann JD, Eack SM, Keshavan MS, Pascual-Leone A, Halko MAJuly 2019Not Determined
30630078Create StudyIndividual variation in brain network topology is linked to emotional intelligence.NeuroImageLing, George; Lee, Ivy; Guimond, Synthia; Lutz, Olivia; Tandon, Neeraj; Nawaz, Uzma; Öngür, Dost; Eack, Shaun; E Lewandowski, Kathryn; Keshavan, Matcheri; Brady Jr, RoscoeApril 2019Not Determined
30580895Create StudyValidation of the MUSIC Model of Motivation Inventory for use with cognitive training for schizophrenia spectrum disorders: A multinational study.Schizophrenia researchHansen, Marie C; Jones, Brett D; Eack, Shaun M; Glenthøj, Louise Birkedal; Ikezawa, Satoru; Iwane, Tatsuro; Kidd, Sean A; Lepage, Martin; Lindenmayer, Jean-Pierre; Ljuri, Isidora; Maida, Keiko; Matsuda, Yasuhiro; Nakagome, Kazuyuki; Nordentoft, Merete; Ozog, Veronica; Penney, Danielle; Saperstein, Alice M; Sunaga, Atsuko; Vinogradov, Sophia; Virdee, Gursharan; Wojtalik, Jessica A; Medalia, AliceApril 2019Not Determined
30505392Create StudyUsing Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.Journal of the Society for Social Work and ResearchWojtalik, Jessica A; Eack, Shaun M; Smith, Matthew J; Keshavan, Matcheri SJanuary 2018Not Determined
30216862Create StudySerum anticholinergicity is associated with reduced prefrontal brain function in early course schizophrenia.Psychiatry research. NeuroimagingSchreiber SR, Wojtalik JA, Walker CP, Cho RY, Eack SM, Keshavan MSNovember 2018Not Determined
29524918Create StudyImpaired regulation of emotional distractors during working memory load in schizophrenia.Journal of psychiatric researchGuimond, Synthia; Padani, Shezal; Lutz, Olivia; Eack, Shaun; Thermenos, Heidi; Keshavan, MatcheriJune 2018Not Determined
29045770Create StudyTreatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control.The Journal of clinical psychiatryLewandowski, Kathryn E; Sperry, Sarah H; Cohen, Bruce M; Norris, Lesley A; Fitzmaurice, Garrett M; Ongur, Dost; Keshavan, Matcheri S2017Not Determined
28882686Create StudyEffects of peer social interaction on performance during computerized cognitive remediation therapy in patients with early course schizophrenia: A pilot study.Schizophrenia researchSandoval, Luis R; González, Betzamel López; Stone, William S; Guimond, Synthia; Rivas, Cristina Torres; Sheynberg, David; Kuo, Susan S; Eack, Shaun; Keshavan, Matcheri SJanuary 1, 2019Not Determined
28291690Create StudySocial-cognitive brain function and connectivity during visual perspective-taking in autism and schizophrenia.Schizophrenia researchEack, Shaun M; Wojtalik, Jessica A; Keshavan, Matcheri S; Minshew, Nancy JMay 2017Not Determined
27894892Create StudyLongitudinal functional brain imaging study in early course schizophrenia before and after cognitive enhancement therapy.NeuroImageKeshavan MS, Eack SM, Prasad KM, Haller CS, Cho RYMay 2017Not Determined
27713804Create StudyCognitive Enhancement Therapy Improves Resting-State Functional Connectivity in Early Course Schizophrenia.Journal of the Society for Social Work and ResearchEack, Shaun M; Newhill, Christina E; Keshavan, Matcheri SJanuary 2016Not Determined
25997775Create StudyDysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.Development and psychopathologyKeshavan, Matcheri S; Mehta, Urvakhsh Meherwan; Padmanabhan, Jaya L; Shah, Jai LMay 2015Not Relevant
25883891Create StudyNeuroimaging Biomarkers for Psychosis.Current behavioral neuroscience reportsHager, Brandon M; Keshavan, Matcheri SMarch 6, 2015Not Determined
25156338Create StudyDetecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery.Schizophrenia researchGray, Bradley E; McMahon, Robert P; Green, Michael F; Seidman, Larry J; Mesholam-Gately, Raquelle I; Kern, Robert S; Nuechterlein, Keith H; Keefe, Richard S; Gold, James MOctober 2014Not Relevant
24700194Create StudyCognitive training in mental disorders: update and future directions.The American journal of psychiatryKeshavan, Matcheri S; Vinogradov, Sophia; Rumsey, Judith; Sherrill, Joel; Wagner, AnnMay 2014Not Determined
24055199Create StudyPrefrontal cortical dysfunction during visual perspective-taking in schizophrenia.Schizophrenia researchEack SM, Wojtalik JA, Newhill CE, Keshavan MS, Phillips MLNovember 2013Not Determined
23885163Create StudyEffects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial.Research on social work practiceEack, Shaun M; Hogarty, Gerard E; Greenwald, Deborah P; Hogarty, Susan S; Keshavan, Matcheri SJanuary 27, 2011Not Determined
23623449Create StudyNegative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy.Psychiatry researchEack SM, Mesholam-Gately RI, Greenwald DP, Hogarty SS, Keshavan MSAugust 30, 2013Not Determined
23340377Create StudySexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.Schizophrenia researchWalder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EFMarch 2013Not Relevant
23158779Create StudyPrefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.Psychiatry researchWojtalik JA, Eack SM, Pollock BG, Keshavan MSNovember 30, 2012Not Determined
23041620Create StudyStructural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia.Progress in neuro-psychopharmacology & biological psychiatryWojtalik JA, Eack SM, Keshavan MSJanuary 10, 2013Not Determined
21645997Create StudyA broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia.Schizophrenia researchKeshavan, Matcheri S; Eack, Shaun M; Wojtalik, Jessica A; Prasad, Konasale M R; Francis, Alan N; Bhojraj, Tejas S; Greenwald, Deborah P; Hogarty, Susan SAugust 2011Not Determined
21167689Create StudyIs cognitive enhancement therapy equally effective for patients with schizophrenia and schizoaffective disorder?Schizophrenia researchLewandowski KE, Eack SM, Hogarty SS, Greenwald DP, Keshavan MSFebruary 2011Not Determined
20860867Create StudyMechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia.Psychological medicineEack, S M; Pogue-Geile, M F; Greenwald, D P; Hogarty, S S; Keshavan, M SJune 2011Not Determined
20472402Create StudyOne-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia.Schizophrenia researchEack SM, Greenwald DP, Hogarty SS, Keshavan MSJuly 2010Not Determined
20439824Create StudyNeuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.Archives of general psychiatryEack, Shaun M; Hogarty, Gerard E; Cho, Raymond Y; Prasad, Konasale M R; Greenwald, Deborah P; Hogarty, Susan S; Keshavan, Matcheri SJuly 2010Not Determined
19880464Create StudyCognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.Psychiatric services (Washington, D.C.)Eack, Shaun M; Greenwald, Deborah P; Hogarty, Susan S; Cooley, Susan J; DiBarry, Ann Louise; Montrose, Debra M; Keshavan, Matcheri SNovember 2009Not Determined
19501486Create StudyEvidence of factorial variance of the Mayer-Salovey-Caruso Emotional Intelligence Test across schizophrenia and normative samples.Schizophrenia researchEack SM, Pogue-Geile MF, Greeno CG, Keshavan MSOctober 2009Not Determined
18648021Create StudyAssessing social-cognitive deficits in schizophrenia with the Mayer-Salovey-Caruso Emotional Intelligence Test.Schizophrenia bulletinEack SM, Greeno CG, Pogue-Geile MF, Newhill CE, Hogarty GE, Keshavan MSMarch 2010Not Determined
18603414Create StudyNeuroanatomical substrates of foresight in schizophrenia.Schizophrenia researchEack SM, George MM, Prasad KM, Keshavan MSAugust 2008Not Determined
18308905Create StudyForesight in schizophrenia: a potentially unique and relevant factor to functional disability.Psychiatric services (Washington, D.C.)Eack, Shaun M; Keshavan, Matcheri SMarch 2008Not Determined
18034695Create StudyfMRI BOLD response to the eyes task in offspring from multiplex alcohol dependence families.Alcoholism, clinical and experimental researchHill SY, Kostelnik B, Holmes B, Goradia D, McDermott M, Diwadkar V, Keshavan MDecember 2007Not Determined
17601524Create StudyReduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis.Clinical biochemistryReddy RD, Keshavan MS, Yao JKSeptember 2007Not Determined
17055227Create StudyCognitive enhancement therapy improves emotional intelligence in early course schizophrenia: preliminary effects.Schizophrenia researchEack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MSJanuary 2007Not Determined
helpcenter.collection.publications-tab

NDA Help Center

Collection - Publications

The number of Publications is displayed in parentheses next to the tab name. Clicking on any of the Publication Titles will open the Publication in a new internet browsing tab.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may mark a publication as either Relevant or Not Relevant in the Status column.

Frequently Asked Questions

  • How can I determine if a publication is relevant?
    Publications are considered relevant to a collection when the data shared is directly related to the project or collection.
  • Where does the NDA get the publications?
    PubMed, an online library containing journals, articles, and medical research. Sponsored by NiH and National Library of Medicine (NLM).

Glossary

  • Create Study
    A link to the Create an NDA Study page that can be clicked to start creating an NDA Study with information such as the title, journal and authors automatically populated.
  • Not Determined Publication
    Indicates that the publication has not yet been reviewed and/or marked as Relevant or Not Relevant so it has not been determined whether an NDA Study is expected.
  • Not Relevant Publication
    A publication that is not based on data related to the aims of the grant/project associated with the Collection or not based on any data such as a review article and, therefore, an NDA Study is not expected to be created.
  • PubMed
    PubMed provides citation information for biomedical and life sciences publications and is managed by the U.S. National Institutes of Health's National Library of Medicine.
  • PubMed ID
    The PUBMed ID is the unique ID number for the publication as recorded in the PubMed database.
  • Relevant Publication
    A publication that is based on data related to the aims of the grant/project associated with the Collection and, therefore, an NDA Study is expected to be created.

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Associated Studies

Studies that have been defined using data from a Collection are important criteria to determine the value of data shared. The number of subjects column displays the counts from this Collection that are included in a Study, out of the total number of subjects in that study. The Data Use column represents whether or not the study is a primary analysis of the data or a secondary analysis. State indicates whether the study is private or shared with the research community.

Study NameAbstractCollection/Study SubjectsData UsageState
No records found.
helpcenter.collection.associated-studies-tab

NDA Help Center

Collection - Associated Studies

Clicking on the Study Title will open the study details in a new internet browser tab. The Abstract is available for viewing, providing the background explanation of the study, as provided by the Collection Owner.

Primary v. Secondary Analysis: The Data Usage column will have one of these two choices. An associated study that is listed as being used for Primary Analysis indicates at least some and potentially all of the data used was originally collected by the creator of the NDA Study. Secondary Analysis indicates the Study owner was not involved in the collection of data, and may be used as supporting data.

Private v. Shared State: Studies that remain private indicate the associated study is only available to users who are able to access the collection. A shared study is accessible to the general public.

Frequently Asked Questions

  • How do I associate a study to my collection?
    Studies are associated to the Collection automatically when the data is defined in the Study.

Glossary

  • Associated Studies Tab
    A tab in a Collection that lists the NDA Studies that have been created using data from that Collection including both Primary and Secondary Analysis NDA Studies.
Edit